anti-CD69 antibody [FN50]

Arigo Biolaboratories

anti-CD69 antibody [FN50]

23

Functional Assay, Flow Cytometry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, Other Application

Research Use Only

Monoclonal

FN50

1 mg/ml

Unconjugated

>95%

CD69

CD69 molecule

activation inducer molecule (AIM/CD69); AIM; BL-AC/P26; CD69 antigen (p60, early T-cell activation antigen); CLEC2C; C-type lectin domain family 2, member C; EA1; early activation antigen CD69; early lymphocyte activation antigen; early T-cell activation antigen p60; GP32/28; leukocyte surface antigen Leu-23; MLR-3

Mouse

IgG1

CD69 (C-type lectin domain family 2 C, CLEC2C, also known as AIM) is one of the earliest inducible cell surface molecules acquired during leukocyte activation. This glycoprotein serves as a lectin-type receptor in lymphocytes, NK cells and platelets; it is involved in lymphocyte proliferation. CD69 expression is counteracted on T cells in the AIDS stage of HIV infection, and may be also predictive for clinical response to chemoimmunotherapy.

Human

-20°C

12352203